N. Vogelzang
- Surgery top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Oncology top 10%
- Neurology top 5%
- Co-authors
- Susan HalabiGeorge J. BoslNancy L. GellerLawrence H. EinhornDean F. BajorinEmily CrawfordPaul J. CatalanoPatrick J. Loehrer
- Topics
- Prostate Cancer Treatment and Research (14 papers)Testicular diseases and treatments (11 papers)Neuroblastoma Research and Treatments (6 papers)
- Partner nations
- United StatesUnited KingdomTaiwan
In The Last Decade
N. Vogelzang
47 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 71
- Surgery 707
- Pulmonary and Respiratory Medicine 519
- Molecular Biology 391
- Oncology 270
- Neurology 258
Countries citing papers authored by N. Vogelzang
This map shows the geographic impact of N. Vogelzang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Vogelzang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Vogelzang more than expected).
Fields of papers citing papers by N. Vogelzang
This network shows the impact of papers produced by N. Vogelzang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Vogelzang. The network helps show where N. Vogelzang may publish in the future.
Co-authorship network of co-authors of N. Vogelzang
This figure shows the co-authorship network connecting the top 25 collaborators of N. Vogelzang. A scholar is included among the top collaborators of N. Vogelzang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Vogelzang. N. Vogelzang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 1 | |
| 3 | Hematologic safety of radium-223 dichloride (Ra-223) in the phase 3 ALSYMPCA trial in castration-resistant prostate cancer (CRPC) patients with bone metastases : baseline prognostic factor subgroup analysis | 3 |
| 4 | Bladder, Penis and Urethral Cancer, and Basic Principles of Oncology Re: Do Mixed Histological Features Affect Survival Benefit from Neoadjuvant Platinum-Based Combination Chemotherapy in Patients with Locally Advanced Bladder Cancer? A Secondary Analysis of Southwest Oncology Group-Directed Intergroup Study (S8710) | 14 |
| 5 | 5 | |
| 6 | 1 | |
| 7 | 31 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 15 | |
| 12 | 46 | |
| 13 | 204 | |
| 14 | 7 | |
| 15 | 33 | |
| 16 | 97 | |
| 17 | 10 | |
| 18 | 183 | |
| 19 | 92 | |
| 20 | 57 |
About N. Vogelzang
N. Vogelzang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 47 papers that have together received 1.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (14 papers), Testicular diseases and treatments (11 papers) and Neuroblastoma Research and Treatments (6 papers). The work is most often cited by research in Reproductive Medicine (214 citations), Neurology (258 citations) and Surgery (707 citations). N. Vogelzang has collaborated with scholars based in United States, United Kingdom and Taiwan. Frequent co-authors include Susan Halabi, George J. Bosl, Nancy L. Geller, Lawrence H. Einhorn, Dean F. Bajorin, Emily Crawford, Paul J. Catalano, Patrick J. Loehrer, Craig R. Nichols and Eric J. Small. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.